JUP and rheumatoid arthritis: When combining the findings from 16S rRNA pyrosequencing and/or a positive anti-Pg P18γ antibody response (against a chaperone peptide), the overall exposure to Pg was essentially the same for RA patients (78%) and the controls (83%), which is comparable to our present findings.